Literature DB >> 16876317

The role of tissue transglutaminase in 1-methyl-4-phenylpyridinium (MPP+)-induced toxicity in differentiated human SH-SY5Y neuroblastoma cells.

Katy E Beck1, Luigi A De Girolamo, Martin Griffin, E Ellen Billett.   

Abstract

Tissue transglutaminase (TG2) can induce post-translational modification of proteins, resulting in protein cross-linking or incorporation of polyamines into substrates, and can also function as a signal transducing G protein. The role of TG2 in the formation of insoluble cross-links has led to its implication in some neurodegenerative conditions. Exposure of pre-differentiated SH-SY5Y cells to the Parkinsonian neurotoxin 1-methyl-4-phenylpyridinium ion (MPP(+)) resulted in significant dose-dependent reductions in TG2 protein levels, measured by probing Western blots with a TG2-specific antibody. Transglutaminase (TG) transamidating activity, on the other hand, monitored by incorporation of a polyamine pseudo-substrate into cellular proteins, was increased. Inhibitors of TG (putrescine) and TG2 (R283) exacerbated MPP(+) toxicity, suggesting that activation of TG2 may promote a survival response in this toxicity paradigm.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16876317     DOI: 10.1016/j.neulet.2006.06.061

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  8 in total

1.  Sphingosine kinase 1 and sphingosine-1-phosphate in oxidative stress evoked by 1-methyl-4-phenylpyridinium (MPP+) in human dopaminergic neuronal cells.

Authors:  Joanna Pyszko; Joanna B Strosznajder
Journal:  Mol Neurobiol       Date:  2014-01-09       Impact factor: 5.590

2.  Amphotericin B Increases Transglutaminase 2 Expression Associated with Upregulation of Endocytotic Activity in Mouse Microglial Cell Line BV-2.

Authors:  Kenji Kawabe; Katsura Takano; Mitsuaki Moriyama; Yoichi Nakamura
Journal:  Neurochem Res       Date:  2017-02-21       Impact factor: 3.996

3.  Tissue transglutaminase expression and activity in normal and glaucomatous human trabecular meshwork cells and tissues.

Authors:  Tara Tovar-Vidales; Rouel Roque; Abbot F Clark; Robert J Wordinger
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-02       Impact factor: 4.799

Review 4.  Type 2 transglutaminase in Huntington's disease: a double-edged sword with clinical potential.

Authors:  P G Mastroberardino; M Piacentini
Journal:  J Intern Med       Date:  2010-11       Impact factor: 8.989

Review 5.  New insight into transglutaminase 2 and link to neurodegenerative diseases.

Authors:  Boram Min; Kwang Chul Chung
Journal:  BMB Rep       Date:  2018-01       Impact factor: 4.778

6.  Pre-clinical Studies Identifying Molecular Pathways of Neuroinflammation in Parkinson's Disease: A Systematic Review.

Authors:  Mobina Fathi; Kimia Vakili; Shirin Yaghoobpoor; Mohammad Sadegh Qadirifard; Mohammadreza Kosari; Navid Naghsh; Afsaneh Asgari Taei; Andis Klegeris; Mina Dehghani; Ashkan Bahrami; Hamed Taheri; Ashraf Mohamadkhani; Ramtin Hajibeygi; Mostafa Rezaei Tavirani; Fatemeh Sayehmiri
Journal:  Front Aging Neurosci       Date:  2022-07-04       Impact factor: 5.702

7.  Differential Effects of Methyl-4-Phenylpyridinium Ion, Rotenone, and Paraquat on Differentiated SH-SY5Y Cells.

Authors:  João Barbosa Martins; Maria de Lourdes Bastos; Félix Carvalho; João Paulo Capela
Journal:  J Toxicol       Date:  2013-03-20

8.  Transglutaminase-2 Is Involved in All-Trans Retinoic Acid-Induced Invasion and Matrix Metalloproteinases Expression of SH-SY5Y Neuroblastoma Cells via NF-κB Pathway.

Authors:  Hye Ja Lee; Mi Kyung Park; Hyun Cheol Bae; Hee Jung Yoon; Soo Youl Kim; Chang Hoon Lee
Journal:  Biomol Ther (Seoul)       Date:  2012-05       Impact factor: 4.634

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.